Basic Information
| LncRNA/CircRNA Name | LINC01116 |
| Synonyms | NA |
| Region | GRCh38_2:176629589-176637931 |
| Ensemble | ENSG00000163364 |
| Refseq | NR_040001 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | qRT-PCR, Western blot |
| Sample | NPC cell lines |
| Expression Pattern | up-regulated |
| Function Description | Here, we found that LINC01116 was highly expressed in NPC cell lines, and inhibition of LINC01116 notably restrained cell viability, proliferation, and migration in NPC cells. |
| Pubmed ID | 31703161 |
| Year | 2019 |
| Title | LINC01116 accelerates nasopharyngeal carcinoma progression based on its enhancement on MYC transcription activity |
External Links
| Links for LINC01116 | GenBank HGNC NONCODE |
| Links for nasopharyngeal cancer | OMIM COSMIC |